vTv Therapeutics Inc. - Class A Common Stock (VTVT)
VTVT Stock Chart More Charts
VTVT Price/Volume Stats
| Current price | $3.28 |
| Prev. close | $3.39 |
| Day low | $3.05 |
| Day high | $3.63 |
| 50-day MA | $1.40 |
| 200-day MA | $3.03 |
| 52-week high | $8.40 |
| 52-week low | $0.65 |
| Volume | 2,181,900 |
| Avg. volume | 1,465,110 |
| Dividend yield | N/A |
| Market Cap | 113.29M |
VTVT Returns
| 1-mo | 302.95% |
| 3-mo | 123.13% |
| 6-mo | 49.09% |
| 1-year | -57.79% |
| 3-year | -59.61% |
| 5-year | N/A |
| YTD | -45.42% |
| 2017 | 24.43% |
| 2016 | -29.07% |
| 2015 | N/A |
| 2014 | N/A |
| 2013 | N/A |
vTv Therapeutics Inc. - Class A Common Stock (VTVT) Company Bio
vTv Therapeutics Inc., a biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates worldwide. The company was founded in 2015 and is based in High Point, North Carolina.
Loading social stream, please wait...